References

  1. Korn D. Congenital hypoplastic thrombocytopenia. Am J Clin Pathol. 1962 Apr;37:405-13. PubMed | Google Scholar

  2. Gewirtz AM, Hoffman R. Human megakaryocyte production: cell biology and clinical considerations. Hematol Oncol Clin North Am. 1990 Feb;4(1):43-64. PubMed | Google Scholar

  3. Trimble MS, Glynn MFX, Brain MC. Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin. Am J Hem. 1991 ; 37 (2) : 126-127. PubMed | Google Scholar

  4. Lown R, Rhodes E, BosworthJ, Shannon MS, Stasi R. Acquired amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor agonists. Clin Adv Hematol Oncol. 2010 Nov;8(11):809-12. PubMed | Google Scholar

  5. Felderbauer P, Ritter PR, Mattern D, Schmitz F, Bulut K, Ansorge N et al. Acquired pure megakaryocytic aplasia: a separate haematological disease entity or a syndrome with multiple causes. Eur J Haematol. 2004 Jun;72(6):451-4. PubMed | Google Scholar

  6. Lai DW, Loughran TP, Maciejewski JP, Sasu S, Song SX, Epling-Burnette PK et al. Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia. Leuk Res. 2008 May;32(5):823-7. PubMed | Google Scholar

  7. Erkurt MA, Kaya E, Baran M, Tmen EY, Fienel S, Kuku R et al. Rapid progression of acquired amegakaryocytic thrombocytopenia to myelodysplastic syndrome: case report. Turk J Haematol. 2005;22(4): 205-208. PubMed | Google Scholar

  8. Mulroy E, Gleeson S, Chiruka S, Danazol. Effective option in acquired Amegakaryocytic thrombocytopaenic purpura; Case Rep. Hematol. 2015;2015:171253. PubMed | Google Scholar

  9. Mirzania M, Khalili S, Hasanpoor A, Shamshiri RA. Anti-CD20 antibody is effective in the patient with refractory amegakaryocytic thrombocytopenia, 25 months follow up. Int J Hematol Oncol Stem Cell Res. 2014; 8(2): 41-44. PubMed | Google Scholar

  10. Cela I, Miller IJ, Katz RS, Rizman A, Shammo JM .Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with Systemic Lupus Erythematosus (SLE). Clin Adv Hematol Oncol. 2010 Nov;8(11):809-12. PubMed | Google Scholar